Loading...
XKRX
099190
Market cap311mUSD
Dec 05, Last price  
16,730.00KRW
1D
-0.54%
1Q
-0.95%
Jan 2017
13.81%
IPO
90.84%
Name

I Sens Inc

Chart & Performance

D1W1MN
XKRX:099190 chart
P/E
—
P/S
1.58
EPS
—
Div Yield, %
—
Shrs. gr., 5y
0.29%
Rev. gr., 5y
8.93%
Revenues
291.14b
+9.81%
66,549,429,80082,862,589,51095,608,058,130101,920,703,199132,468,196,930156,963,800,842172,996,578,932189,844,257,361203,707,640,796232,934,791,026264,837,131,104265,120,260,370291,137,904,000
Net income
-1.79b
L
8,744,729,07018,641,928,16014,466,160,94014,715,903,02917,560,919,12115,730,466,07522,619,253,76923,425,871,70826,838,557,96025,451,013,45016,138,019,3103,709,063,090-1,794,054,000
CFO
22.96b
+75.99%
5,102,430,35016,190,153,21017,845,210,70020,400,604,58912,065,120,82622,247,810,24419,508,172,13937,950,911,70434,614,942,25517,223,810,7396,653,468,56313,045,086,88022,958,071,000
Dividend
Dec 27, 2023175 KRW/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

i-SENS, Inc. provides diagnostic biosensors in South Korea. The company offers point of care testing devices, such as HbA1c, blood gas, electrolyte, and PT/INR analyzers; CareSens blood glucose monitoring systems; and lancing and other ancillary devices, as well as diabetes management services. It exports its products to approximately 110 countries, including the United States, Japan, and Europe. The company was founded in 2000 and is headquartered in Seoul, South Korea.
URL
https://i-sens.co.kr/
IPO date
Jan 30, 2013
Employees
Domiciled in
KR
Incorporated in
KR

Valuation

Title
KRW in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT